What can modelling tell us about HIV and TB that we don’t already know?

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

Modelling the impact of male circumcision on HIV/AIDS in sub-Saharan Africa Brian Williams, SACEMA 14 November 2007.
TB and HIV: Tightly Linked… and Why We Should Care.
Unit 1: Introduction to STI Surveillance in Africa and the Relationship between STIs and HIV #4-1-1.
Understanding Epidemics HIV/AIDS 1.What is HIV/AIDS?What is HIV/AIDS? 2.Studying HIV/AIDS?Studying HIV/AIDS? 3.Some common misconceptionsSome common misconceptions.
1 Global AIDS Epidemic The first AIDS case was diagnosed in years later, 20 million people are dead and 37.8 million people (range: 34.6–42.3 million)
Modelling HIV/AIDS in Southern Africa Centre for Actuarial Research (CARe) A Research Unit of the University of Cape Town.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Attaining Realistic and Substantial Reductions in HIV Incidence: Model Projections of Combining Microbicide and Male Circumcision interventions in Rural.
Created by Mrs. Jarmer March 2011 Main Resource:
Modelling changes in HIV prevalence among women attending antenatal clinics in Uganda Brian Williams.
Topic 2 The prevalence of HIV/AIDS and its potential impact on individuals, communities and countries Slide 2.1.
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
AIDS 2014 – Ending the adolescent AIDS epidemic Ungdom og hiv Anne May Andersen, Norad.
The Global Plan to Stop TB, (1)
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Monitoring the effects of ARV treatment programmes on prevention Gabriel Mwaluko 1, Mark Urassa,2, John Changalucha,2, Ties Boerma 3 1 TANESA Project,
4. HIV/AIDS in Africa Takashi Yamano Development Issues in Africa Spring 2007.
HIV/AIDS In Botswana. Learning objective…. Explain the impact of HIV and Aids in one African country (Botswana)
Modelling the role of household versus community transmission of TB in Zimbabwe Georgie Hughes Supervisor: Dr Christine Currie (University of Southampton)
Chapter 1: An Overview of the HIV/AIDS Epidemic Module 1, Chapter 1.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
HIV Declines in Young Adults in South India Rajesh Kumar, MD Prof. of Community Medicine School of Public Health Post Graduate Institute of Medical Education.
Map of HIV Prevalence Worldwide
Epidemiology of TB and HIV/AIDS in the Caribbean Module 1 – March 2010.
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders.
Pro Vice-Chancellor (Research), University of KwaZulu-Natal Director: CAPRISA - Centre for the AIDS Programme of Research in SA Professor in Clinical Epidemiology,
GLOBAL UNITED CHILDREN’S FOUNDATION, Inc Presents “Using Education to Contain the Spread of HIV/AIDS in Africa and Expand Treatment in Rural Communities.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
HIV and AIDS Epidemic: Potential Contribution from DSS sites Nyovani Madise, PhD Centre for Global Health, Population, Poverty & Policy.
Unit 6: Second-Generation HIV/AIDS Surveillance #1-6-1.
Home economics 9 th grade – 4 th partial. Sexual education is instruction on issues relating to human sexualityincluding:  human sexual anatomy  sexual.
Salim S. Abdool Karim, MBChB, PhD and Quarraisha Abdool Karim, PhD.
Modelling the demographic impact of HIV/AIDS Joubert Ferreira (President ASSA) Wim Els (Executive Director) David Schneider (Convenor AIDS Committee) Rob.
BISEXUAL CONCURRENCY,BISEXUAL PARTNESHIPS,AND HIV AMONG SOUTHERN AFRICA MEN WHO HAVE SEX WITH MEN (MSM) Presenter: Gift Trapence Organisation: Centre for.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden.
HIV vulnerabilities of sex workers in Europe
A new method for estimating national and regional ART need Basia Zaba, Raphael Isingo, Alison Wringe, Milly Marston, and Mark Urassa TAZAMA / NACP seminar.
Understanding the impact of disease control: TB epidemiology and the GFATM.
Global HIV Epidemiology Carey Farquhar, MD, MPH Grace John-Stewart MD, PhD Departments of Medicine, Epidemiology and Global Health.
© Imperial College LondonPage 1 Understanding the current spread of HIV Geoff Garnett.
Katarina Grande, HIV Surveillance Coordinator Casey Schumann, HIV Epidemiologist Wisconsin Department of Health Services Statewide Action Planning Group.
Zindoga Mukandavire Social and Mathematical Epidemiology Group London School of Hygiene and Tropical Medicine, UK Improving health worldwide
Mathematical modelling of male circumcision in sub-Saharan Africa predicts significant reduction in HIV prevalence Greg Londish 1, John Murray 1,2 1 School.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Mortality: Model Life Tables
Claudia L. Moreno, Ph.D., MSW
How complicated do we want to make this?
financial requirements
Nazir Ismail CTB/NICD & WHO-SRL & UP
اپيدميولوژي و كنترل سِل
PROGRESS IN GLOBAL TB CONTROL
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Bhutan.
Countries with Genotype data available
Countries having introduced HepB vaccine
Kevin M De Cock MD CDC Kenya Nairobi, September 21, 2003
Countries Using Mening Vaccine in National Immunization Schedule 2011
Peter Godfrey-Faussett for Charlotte Watts
PROGRESS IN GLOBAL TB CONTROL
Managing TB in the era of HIV
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
FORECASTING THE IMPACT OF HIV/AIDS NATIONALLY AND IN SUB-POPULATIONS
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
HIV/AIDS In Botswana.
Presentation transcript:

What can modelling tell us about HIV and TB that we don’t already know?

I am not interested in this or that phenomenon, in the spectrum of this or that element. I want to know [God’s] thoughts, the rest are details. Albert Einstein

Nature only uses the longest threads to weave her patterns, so each small piece of her fabric reveals the organization of the entire tapestry. Richard Feynman

1.Why is there so much HIV in southern Africa and so little in India and Latin America? 2.Can we control TB without controlling AIDS? 3.Why does survival after infection with HIV vary from months to decades? 4.Is migration important in determining the spread of HIV. Questions for Einstein

1.Is the prevalence of HIV in Harare really declining at 10% per year? 2.Are CD4 counts a useful measure of immune status for people with HIV? 3.Of TB cases in HIV+ people, what proportion are new and what proportion are reactivations? 4.What is the duration of TB disease in HIV+ and HIV- people? Questions for Feynman

Theories and models A model is the expression of a theory 1.Models should be as simple as possible but no simpler. 2.Always start from what is known. 3.Only add complexity as the data or the questions demand it.

15 – 40 5 – 15 1 – – – – 0.1 No data Prevalence of HIV among adults (%)

Highest per capita TB incidence in Africa 25 to to to 299 < to or more No Estimate per population The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2002

Prevalence of HIV in adults (2005) North India: 0.2% South India: 1.5% Brazil: 0.7% West Africa: 3% East Africa: 5% South Africa: 21% (Median values in Africa)

Kinds of models 1.Dimensional models 2.Analytical models 3.Simple compartmental models 4.Complex compartmental models 5.Stochastic models 6.Micro-simulation models 7.Network models

Risk factors for HIV infection Behavioural Number of sexual partners, condom use Biological Other sexually transmitted infections, gender Cultural Male circumcision, premarital sex Economic Poverty and commercial sex work Social Peer pressure and gender violence Occupational Truck drivers and mine workers

Risk factors for TB Behavioural Alcoholism, smoking Biological Gender, possibly race, age, HIV Economic Poverty, crowding, indoor solid fuel Occupational Silica exposure

Three key concepts R 0 : how many people does one person infect? Generation time T 0 : How long does it take? Steady state P 0 : Where does it settle down?

Doubling time = 15 months R 0 = 120/15 = 8

1. Grosskurth, H., et al., Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet, : p Laga, M. STD control for HIV prevention--it works! Lancet, : p Syndromic management of sexually transmitted diseases, Mwanza, Tanzania Prevalence of STIs ~ 10% Curable STIs increase transmission ~ 5 times STIs increase HIV incidence by 0.1   1 = 1.4 times Measured incidence in two groups of villages Control: 0.9%/yr Intervention: 0.6%/yr Ratio: 1.6 (1.2–2.2) 1 It works! 2

Mwanza: Grosskurth, H., et al., Lancet, 1995 Rakai: Wawer, M.J., et al., Lancet, 1999 Masaka: Kamali, A., et al., Lancet, 2003 Control Interv. Ratio Mwanza (SM) (1.18–2.22) Rakai (MT) (0.86–1.23) Masaka (IEC+SM) (0.63–1.59) SM: syndromic management; MT: mass treatment; IEC: information, education and counselling. Three trials

STDSim: Micro-simulation model Individual based Stochastic Health care STI natural history and transmission Sexual behaviour Demography Interventions

Richard White’s conclusion …in widely disseminated HIV epidemics … STI treatment may [not be an] effective HIV prevention strategy. In less advanced … HIV epidemics [it may be an] effective … strategy, and it remains useful … in sub-populations with very high rates of STIs, such as sex workers, their clients and regular partners. Richard White Variability in the effectiveness of STI treatment interventions to prevent HIV transmission in Eastern and Southern Africa, Ph.D. Thesis. LSHTM, 2006

 = birth rate N = S + I = rate at which new infections occur  = mortality  S I I  N S I /N  I S  The basic model

R 0 = 3.3

 = birth rate N = S + I = infection rate  I = Weibull mortality  S I I  N S I /N  I S Normal (Weibull 2) Exponential (Weibull 1)

 = birth rate N = population = e –  P  I = Weibull mort. ~ ~  S I I  N S I /N  I S  –P–P e Heterogeneity in sexual behaviour

~  S I I  N S I /N  I S ~  = birth rate N = population = C(t)  I = mortality ~ ~ C(t)C(t) Including control

~  S I I  N S I /N  I S *  = birth rate N = population = e  I = mortality ~ * –M–M –M–M e Mortality leads to behaviour change

Nairobi 6 yr Nunn P et al. Tuberculosis control in the era of HIV. Nat Rev Immunol Oct;5(10):

TB incidence among gold miners in SA Corbett EL Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB. J Infect Dis. 2003;188:

SS+ Tuberculosis Prevalence Incidence Disease Duration (%) (%/yr) (yr) HIV ( )2.87 ( )0.15 ( ) HIV-0.55 (0.14–0.95)0.48 ( )1.15 ( ) DDR = 0.13 (0.09–0.20) Gold miners in South Africa We define disease duration as prevalence divided by incidence

Repeat the model 4 times, once for each stage of HIV. Use time series of HIV prevalence to determine incidence. Incidence gives rate at which people enter first stage; overall (Weibull) survival determines rate at which people move to next stage. TB-HIV model Williams BG et al. The impact of HIV/AIDS on the control of tuberculosis in India. PNAS :

Impact of interventions on TB cases in Kenya TB incidence/100k/yr Baseline ARV 80% TLTI (6 m) TLTI (life) ARV 100% TB detect. TB cure HIV incid Base line: CDR = 50% CR = 70% Interventions: 1% increase Year Currie, C. et al. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC, : 130.

Percent HIV positive HIV negative Williams BG et al. HIV Infection, Antiretroviral Therapy, and CD4+ Cell Count Distributions in African Populations. J Infect Dis, :

1,000 2, Time to death (yrs) Initial CD4/  L Time to death (yrs) 1,000 2, Initial CD4/  L Model 1 CD4 decline independent of starting value Survival determined by pre- infection CD4 Model 2 Survival independent of starting value CD4 decline determine entirely by starting value and survival distribution 

Spatial Epidemiology of HIV Doubling time = 1 year Life expectancy = 10 years Number of partners = 4 Proportion of random partners chosen at random = 0 (left hand set) or 10% (right hand set) in the following slides. Note that in this model migrants have exactly the same sexual behaviour and individual risk as non-migrants.

1.Can we combine spatial/network models with our more conventional continuous time models of HIV? 2.Can we get a better understanding of the host-viral interaction? 3.What are the population level implications of 2? 4.Do we have enough data to explore fully the joint dynamics of TB and HIV? Questions for all of us

Advice to young epidemiologists Never make a calculation until you know the answer. Make an estimate before every calculation, try a simple biological argument (R 0, generation time, selection, survival, control). Guess the answer to every puzzle. Courage: no one else needs to know what the guess is. Therefore, make it quickly, by instinct. A right guess reinforces this instinct. A wrong guess brings the refreshment of surprise. In either case, life as an epidemiologist, however long, is more fun. Plagiarised from E.F. Taylor and J.A. Wheeler Space-time Physics 1963